McGraw-Hill / Lange rxlist.com (Glyset ) Keywords DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)
Inflammatory reactions and oxidative stress have to be addressed first, making IV glutathione treatments useful in managing irritated skin conditions like acne
You cant rely on them to protect your skin against heavy doses of UV or to reduce the risk of skin cancer
In summary, the DPP-4 inhibitors have demonstrated cardiovascular safety in multiple studies
Ipamorelin is a growth hormone secretagogue that works through a different receptor pathway, triggering a clean, pulsatile release of growth hormone that closely mirrors your bodys natural rhythm
Statistical analyses: two-way ANOVA followed by Tukeys multiple comparisons test ( a , b , k , n , o ), one-way ANOVA followed by Bonferroni post hoc for multiple comparisons ( c , e , j , l , m )